Brokers Issue Forecasts for Aspen Aerogels FY2024 Earnings

Aspen Aerogels, Inc. (NYSE:ASPN) – Investment analysts at B. Riley issued their FY2024 earnings per share (EPS) estimates for shares of Aspen Aerogels in a note issued to investors on Monday, January 6th. B. Riley analyst R. Pfingst expects that the construction company will earn $0.16 per share for the year. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.11 per share. B. Riley also issued estimates for Aspen Aerogels’ Q4 2024 earnings at $0.14 EPS, Q1 2025 earnings at $0.09 EPS, Q2 2025 earnings at $0.12 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.18 EPS, FY2025 earnings at $0.54 EPS, FY2026 earnings at $0.87 EPS and FY2027 earnings at $1.33 EPS.

Other analysts have also recently issued reports about the stock. HC Wainwright restated a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. Roth Mkm decreased their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. Barclays cut their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 12th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research report on Wednesday, November 13th. Finally, Piper Sandler cut their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $30.00.

Aspen Aerogels Stock Performance

Shares of NYSE ASPN opened at $13.18 on Thursday. Aspen Aerogels has a 1 year low of $10.75 and a 1 year high of $33.15. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The stock has a fifty day moving average price of $14.15 and a two-hundred day moving average price of $20.78. The firm has a market cap of $1.08 billion, a P/E ratio of 1,319.32 and a beta of 2.14.

Institutional Investors Weigh In On Aspen Aerogels

Hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of New York Mellon Corp raised its position in Aspen Aerogels by 26.2% during the second quarter. Bank of New York Mellon Corp now owns 226,666 shares of the construction company’s stock valued at $5,406,000 after acquiring an additional 46,988 shares in the last quarter. Rhumbline Advisers lifted its stake in shares of Aspen Aerogels by 13.7% in the 2nd quarter. Rhumbline Advisers now owns 93,226 shares of the construction company’s stock valued at $2,223,000 after purchasing an additional 11,205 shares during the last quarter. Victory Capital Management Inc. bought a new stake in Aspen Aerogels in the second quarter worth $230,000. American Century Companies Inc. increased its position in Aspen Aerogels by 562.3% during the second quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock worth $18,382,000 after buying an additional 654,350 shares during the last quarter. Finally, O Neil Global Advisors Inc. bought a new position in Aspen Aerogels during the second quarter valued at about $506,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.